Clinical Trials Browser

OTHER × Interventional × Non-alcoholic Fatty Liver Disease × Clear all

NCT05884723 2026-05-19

Preoperative Ketogenic Diet for Reduction of Hepatic Steatosis

Phase NA Recruiting

Fatty Liver, Non-alcoholic Fatty Liver Disease

NCT04550481 2026-01-21

Role of Lisinopril in Preventing the Progression of Non-Alcoholic Fatty Liver Disease, RELIEF-NAFLD Study

Phase 2 Active not recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Non-alcoholic Fatty Liver Disease

NCT07146815 2025-08-28

P-CORIGA

Phase NA Completed

Polycystic Ovary Syndrome, Non-alcoholic Fatty Liver Disease

NCT04186260 2025-08-24

A Gender and Culturally Specific Approach to Reduce NAFLD in Mexican-American Men

Phase NA Completed

Obesity, Weight Loss, Multiple Endocrine Neoplasia Type 1, Overweight, Non-alcoholic Fatty Liver Disease

NCT01047735 2025-07-11

TRIABETES

Phase NA Active not recruiting

Behavior, Blindness, Body Weight, Cardiovascular Diseases, Death, Diabetes Mellitus, Diabetes Mellitus, Type 2, Digestive System Diseases, Disease, Hypertension, Inflammation, Insulin Resistance, Liver Diseases, Motor Activity, Myocardial Infarction, Neoplasms, Obesity, Obesity, Morbid, Weight Loss, Atherosclerosis, Renal Insufficiency, Non-alcoholic Fatty Liver Disease

NCT06366425 2025-07-10

HEPGEN

Phase NA Recruiting

Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis, Non-alcoholic Fatty Liver Disease

NCT02500147 2025-07-02

Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)

Phase 4 Terminated

3 enrolled 5 charts

Acne Vulgaris, Amenorrhea, Hirsutism, Polycystic Ovary Syndrome, Metabolic Syndrome, Dyslipidemias, Non-alcoholic Fatty Liver Disease

NCT03534141 2025-05-16

MHALT

Phase NA Terminated

175 enrolled 19 charts

GastrointestinalGenitourinary

Fibrosis, Hepatitis B, Hepatitis C, Carcinoma, Hepatocellular, Hypothermia, Liver Cirrhosis, Alcoholic, Renal Insufficiency, Chronic, Acute Kidney Injury, End Stage Liver Disease, Non-alcoholic Fatty Liver Disease

NCT06918080 2025-04-09

Hepatoprotective Measures for Children at High Risk of NAFLD

Phase 4 Active not recruiting

LymphoidOtherOther hematologic neoplasm

Obesity, Overweight, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Non-alcoholic Fatty Liver Disease

NCT06256289 2024-02-13

Efficacy of Canagliflozin Versus Metformin in Women With Polycystic Ovary Syndrome

Phase 4 Unknown

Polycystic Ovary Syndrome, Non-alcoholic Fatty Liver Disease

NCT06101758 2023-10-26

SARCOLIVER

Phase NA Unknown

Gastrointestinal

Carcinoma, Hepatocellular, Liver Cirrhosis, Non-alcoholic Fatty Liver Disease

NCT02568787 2017-06-14

The Effect of an RBAC Supplement (BRM4) on NAFLD

Phase NA Completed

Non-alcoholic Fatty Liver Disease